Paper Review Records
全部论文审稿周期
11 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
80
天
Inhibiting or harnessing fratricide in CAR-engineered cell therapy: challenges and opportunities
作者
Andrew N. Gorobchenko; Karina T. Umbetova; Abdigaffor Gadaev; Nargiza Mahkamova; Nasiba Sabirova; Aziz Kubaev展开收起
作者单位
1. Department of Infectious Diseases, Institute of Public Health named after F.F. Erisman I.M,. Sechenov First Moscow State Medical University of the Russian Federation (Sechenov University), Moscow, Russia; 2. Department of Internal Medicine in Family Medicine, Tashkent State Medical University, Tashkent, Uzbekistan; 3. Republican Specialized Scientific and Practical Medical Center of Cardiology, Tashkent, Uzbekistan; 4. Bukhara State Pedagogical Institute, Bukhara, Uzbekistan; 5. Department of Maxillofacial Surgery, Samarkand State Medical University, Samarkand, Uzbekistan展开收起
124
天
Pharmacokinetic comparison of cisplatin administration via HIPEC and intravenous infusion in a porcine model
作者
Christina Harlev; Elisabeth Krogsgaard Petersen; Mats Bue; Lone Kjeld Petersen; Johanne Gade Lilleøre; Anne Vibeke Schmedes; Bo Martin Bibby; Maiken Stilling展开收起
作者单位
1. Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; 2. Aarhus Denmark Microdialysis Research (ADMIRE), Orthopaedic Research Laboratory, Aarhus University Hospital, Aarhus, Denmark; 3. Department of Orthopaedic Surgery, Aarhus University Hospital, Aarhus, Denmark; 4. Department of Gynecology and Obstetrics, Odense University Hospital, Odense, Denmark; 5. Department of Clinical Research, University of Southern Denmark, Odense, Denmark; 6. Department of Biochemistry and Immunology, Lillebaelt Hospital, University Hospital of Southern, Vejle, Denmark; 7. Department of Biostatistics, Aarhus University, Aarhus, Denmark展开收起
42
天
Benefit of plasma cystatin C for carboplatin individual dosing in a patient with spinal amyotrophy
作者
Matthieu Gracia; Sabrina Marsili; Julien Vintejoux; Laurence Gladieff; Etienne Chatelut; Fabienne Thomas展开收起
作者单位
1. Univ Toulouse, Oncopole Claudius Regaud, IUCT-Oncopole, Inserm, CRCT, Toulouse, France; 2. Univ Toulouse, Oncopole Claudius-Regaud, IUCT-Oncopole, Toulouse, France展开收起
103
天
Lack of effects of S -equol-containing supplement on the pharmacokinetics of oral hormone therapy drugs for breast cancer
作者
Takehiko Sambe; Chiyo K. Imamura; Noriko Hida; Taigi Yamazaki; Takuya Mizukami; Kakei Ryu; Koya Fukunaga; Taisei Mushiroda; Haruna Miyakawa; Shigeto Uchiyama; Naoki Uchida; Shinichi Kobayashi展开收起
作者单位
1. Division of Clinical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan; 2. Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan; 3. Advanced Cancer Translational Research Institute, Showa Medical University, Tokyo, Japan; 4. Division of Clinical Research and Development, Department of Clinical Pharmacy, Showa Medical University School of Pharmacy, Tokyo, Japan; 5. RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; 6. Nutraceuticals Research Institute, Otsuka Pharmaceutical Co., Ltd., Saga, Japan展开收起
120
天
Presence of drug-drug interactions between esomeprazole and an ALK tyrosine kinase inhibitor (Dirozalkib)
作者
Lin Fang; Xin Jiang; Kexiu Song; Ping Shi; Li Wang; Lingmei Xu; Xianghui Duan; Fei Liu; Feifei Sun; Rongxin Ban; Yaping Ma; Chenjing Wang; Yu Cao展开收起
作者单位
1. Phase I Clinical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, China; 2. Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, China; 3. Clinical Medicine Department, XuanZhu Biopharm Co., Ltd, Shijiazhuang, China; 4. Clinical Pharmacology Department, XuanZhu Biopharm Co., Ltd, Shijiazhuang, China; 5. Biostatistics Department, XuanZhu Biopharm Co., Ltd, Shijiazhuang, China展开收起
48
天
Association of DPYD rs4294451, plasma uracil concentration, and sex with 5-fluorouracil exposure in patients with gastrointestinal cancer
作者
Gabriel A. Brooks; Dylan B. Ness; Kathryn C. Hourdequin; Gregory H. Ripple; Manik Amin; Sierra Lord-Halvorson; Wahab A. Khan; Sophie J. Deharvengt; Vincent Busque; Konstantin H. Dragnev; Wenyan Zhao; Tor D. Tosteson; Lionel D. Lewis展开收起
作者单位
1. Dartmouth Cancer Center, Lebanon, USA; 2. Geisel School of Medicine, Lebanon, USA; 3. Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, USA; 4. University of Chicago Comprehensive Cancer Center, Chicago, USA展开收起
FAQ
CANCER CHEMOTHERAPY AND PHARMACOLOGY审稿要多久?
截至2026-11-19,CrushSCI 收录了 CANCER CHEMOTHERAPY AND PHARMACOLOGY 的 11 篇完整审稿记录。最快一篇从收稿到录用用了 42 天(Benefit of plasma cystatin C for carboplatin individual dosing in a patient with spinal amyotrophy,2025-09-22 收稿,2025-11-03 录用),最慢一篇用了 152 天;平均 99.8 天,中位数 103 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
